The synthesis of polyamine-based peptide amphiphiles (PPAs) is a significant challenge due to the presence of multiple amine nitrogens, which requires judicious use of protecting groups to mask these reactive functionalities. In this paper, we describe a facile method for the preparation of these new class of self-assembling molecules.
Polyamine-based Peptide Amphiphiles (PPAs) are a new class of self-assembling amphiphilic biomaterials-related to the peptide amphiphiles (PAs). Traditional PAs possess charged amino acids as solubilizing groups (lysine, arginine), which are directly connected to a lipid segment or can contain a linker region made of neutral amino acids. Tuning the peptide sequence of PAs can yield diverse morphologies. Similarly, PPAs possess a hydrophobic segment and neutral amino acids, but also contain polyamine molecules as water solubilizing (hydrophilic) groups. As is the case with PAs, PPAs can also self-assemble into diverse morphologies, including small rods, twisted nano-ribbons, and fused nano-sheets, when dissolved in water. However, the presence of both primary and secondary amines on a single polyamine molecule poses a significant challenge when synthesizing PPAs. In this paper, we show a simple protocol, based on literature precedents, to achieve a facile synthesis of PPAs using solid phase peptide synthesis (SPPS). This protocol can be extended to the synthesis of PAs and other similar systems. We also illustrate the steps that are needed for cleavage from the resin, identification, and purification.
Self-assembling peptide amphiphiles (PAs) are a class of biomaterials typically comprised of the following segments: (a) hydrophilic head, (b) linker region, and (c) hydrophobic tail. Most PAs described in the literature possess a hydrophilic head comprised of charged or polar amino acid residues1,2,3,4. PAs have found a wide range of applications in biomedicine including drug delivery, disease diagnostics, regenerative medicine, etc.5. Based on their amino acid sequence, PAs can form a wide variety of nanostructures including spherical micelles, and nano-filaments. We have recently reported a class of hybrid polyamine-based peptide amphiphiles, termed PPAs6. The morphologies, self-assembling kinetics, and metabolic degradation, of these biomaterials, were found to be related to their solubilizing head group. Moreover, the PPA nanostructures did not show toxicity towards mammalian cells (MiaPaCa2 and HeLa cell lines) at the tested concentrations. PPA-based nanocarriers are attractive drug-delivery vehicles because: (1) polyamine uptake and metabolism has been shown to be increased in cancerous cells, (2) cationic nanostructures can achieve endosomal escape7,8, which leads to higher circulation and residence within a cell, and (3) they should have a distinct metabolic profile when compared with PA; for example, they will be more stable towards proteases found in the human body (although they maybe sensitive to other enzymes, such as amine oxidases)9,10. Also, PPAs have been found to have diverse morphologies, physicochemical properties, nanoparticle stiffness, and assembly kinetics depending on the length and charge of individual PPA molecule6. Herein, we describe a detailed protocol for the synthesis, identification, and purification of PPAs that can also be applied to the preparation of PAs or similar hybrid peptide molecules.
Because polyamines are not commonly commercially available in their protected forms, and because protecting the primary and secondary amines of polyamines is of utmost importance for conjugating them with amino acids and other molecules, we have outlined the synthetic steps to achieve their protection. The overall goal of this protocol is to provide a simple method for conjugating polyamines to amino acids. Polyamines lack a carboxylic group; thus, they cannot be coupled to Rink Amide or Wang resins. Instead, resins such as 2-chlorotrityl chloride are recommended for the synthetic protocol. The main challenge for PPA synthesis is the presence of primary and secondary amine functional groups. For our purposes, we protected all the secondary amines in the polyamine while keeping the primary amino group on the polyamine free to allow the coupling reaction. The reaction was done on a solid support following the principles of solid phase peptide synthesis (SPPS) to facilitate the work-up after each coupling and deprotection step. The following protocol is for both the manual and automated synthesis of PPAs (although the verification of some steps will be challenging in an automated system). The synthesis of these molecules can also be carried out on an automated synthesizer or with the aid of a microwave reactor (automated or semi-automated). The reaction scheme has been summarized in Figure 1.
Figure 1: (A) A general reaction scheme for the synthesis of PPAs. (B) Representative polyamines that can be used to synthesized PPAs described here. Please click here to view a larger version of this figure.
1. General Protocol for Synthesis of PPAs
2. PPA Cleavage from Solid Support
The purpose of this step is the cleavage of the PPA from the resin, and to remove the Boc protecting groups from the amino acids and polyamine residues.
3. Identification of the Crude Product Using the MALDI Dried-drop Method
4. Purification of PPAs Using Preparative Reverse-phase High-performance Liquid Chromatography (HPLC) Purification
Solvent | Positively Charged PPAs | Negatively Charged PPAs | ||
0.1% TFA in Water | 0.1% NH3 in Water | |||
0.1% TFA in ACN | 0.1% NH3 in ACN |
Table 1: Solvent Systems. Proposed solvent system for positively and negatively charged PPAs.
PPA Charge | Particle Size | Column Size | Mass of crude PPA |
+ ve Charged | 5 μm | 150 x 30 mm | 170 mg |
- ve Charged | 5 μm | 150 x 30 mm | 170 mg |
+ ve Charged | 5 μm | 150 x 21.2 mm | 90 mg |
- ve Charged | 5 μm | 150 x 21.2 mm | 90 mg |
Table 2: Suggested columns: Column dimensions, particle sizes and the maximum load capacity per injection for C18 reverse phase HPLC columns
Time | Solvent A (Acetonitrile) | Solvent B (Water) | Flow Rate (mL/min) |
0 | 5% | 95% | Flow rate depends on the column packing and its size. |
2 | 5% | 95% | |
35 | 95% | 5% | |
38 | 100% | 0% | |
40 | 5% | 95% |
Table 3: Suggested gradient: Suggested reverse phase gradient showing the relative composition of water vs acetonitrile over a period of time. The flow rate will depend on the column specifications.
5. Storage of PPAs
After the synthesis and purification and before physicochemical or biological evaluation, it is recommended the masses of the PPAs are re-checked and the purity ascertained using analytical HPLC. For material characterization or biological evaluation, PPAs need to have a purity of >95%. Figure 2 shows the HPLC trace (Top) and MALDI spectra (Bottom) confirming the presence of the product. HPLC analytical systems will integrate the area under the curve (AUC) and an AUC >95% can be related to product purity. In UV-based HPLC systems, expect to see a single, sharp peak. MALDI spectra should correspond to that of the calculated molecular weight of the PPA within ±1 Da (depending on the mode of analysis by MALDI).
The self-assembly of the PPAs can be visualized and analyzed using myriad techniques, including Transmission Electron Microscopy (TEM) (Figure 3A, B), Atomic Force Microscopy (AFM) (Figure 3C, D), Small Angle X-ray Scattering (SAXS), Scanning Electron Microscopy (SEM), and Dynamic Light Scattering (DLS). Successful self-assembly will result in well-defined nanostructures in both AFM and TEM. Failure to self-assemble will either result in the formation of irregular aggregates that are several hundred nanometers in size.
Figure 2: Representative Analytical HPLC chromatogram (Top) and MALDI spectrum (bottom) of the PPA C16V2A2Spermine. This figure has been modified from Samad et al. 20176; reused with permission of John Wiley & Sons, 2018. Please click here to view a larger version of this figure.
Figure 3: Representative Transmission electron microscope (TEM) micrograph. (A) TEM image showing the formation of nanofiber and fused nanosheets, (B) Magnified inset showing the formation of bundled nano-sheets, (C) Atomic force microscopy (AFM) micrograph, (D) and height map derived from the micrograph for C16V2A2KDiethyelenetriamine. The X and Y axes of (D) represents nano-sheet width and nano-sheet height respectively. This figure has been modified from Samad et al. 20176; reused with permission of John Wiley & Sons, 2018. Please click here to view a larger version of this figure.
The protocols described here can be used to synthesize PPAs as wells as PAs and related peptide-based molecules (such as hybrid PA-peptoids). Although the synthesis of peptides using SPPS is a straightforward procedure, the synthesis of peptides containing biological homing molecules can be particularly challenging. Polyamines like spermine, spermidine, diethyelenetriamine, etc., can function as homing molecules for targeting cancer cells13. The PPAs can self-assemble into nanostructures with diverse morphologies6. Their positive charge can also aid with longer circulation time (due to endosomal escape) and a different metabolic profile (when compared with traditional PA). However, synthesizing PPAs and their analogues can be a particular challenge because of the presence of primary and secondary amines. The presented synthetic strategy overcomes this challenge by the rational use of orthogonal protecting group. The Dde molecule selectively undergoes reaction only with primary amines11. Boc, on the other hand, reacts indiscriminately with both primary and secondary amines and, therefore, can only be added after the primary amine is protected. We would like to mention that other protecting groups can be used instead of Boc. For example, reaction with acetic anhydride will permanently acetylate the secondary amines (this group will not be removed during cleavage). Likewise, the use of trifluoacetic anhydride will provide a base-sensitive protection while the benzylcarbamate will give a group that can be removed by H2/Ni14. Once the polyamines are protected as needed, the synthesis of the PPA can proceed using standard SPPS. The coupling the hydrophobic tail to the rest of the polyamine-peptide construct not only takes a longer period of time to couple, but also requires twice the molar amount of amino acids. Some of the hydrophobic tails might not dissolve well at room temperature in some traditional solvents or may precipitate even after initial dissolution. Such reactions are best carried out under mild heating (40 °C) by transferring all the reactants to round bottom flask. Alternatively, a jacketed synthesizer vessel might be used to keep the reactants warm throughout the reaction. If available, a microwave synthesizer may aid with the coupling15.
Although many forms of mass spectroscopy are available to determine the masses of PPAs, we used MALDI spectroscopy for the purpose of our identification. We have found MALDI to be more effective in producing the molecular ion peaks, minimizing fragmentation and adduct formation. MALDI should be programmed to generate an ion that corresponds to the most likely ionization state of the PPA. Besides programming the instrument to produce ion of a particular charge, we also need to combine the samples with the appropriate matrix that is suitable for the mode we will use.
PAs often have a tendency to form salt adducts on the MALDI plate. This problem is seen more often with negatively charged molecules. The most common salts are those of sodium (Na+ = 23 Da) and potassium (K+ = 39 Da). These adducts may be suppressed by adding 1–2 µL of acetic acid. The PPAs usually provide the H+ adduct. It is recommended to only use nanopore water or HPLC water throughout the synthetic and purification process to avoid the introduction of additional ions. Borosilicate glass containers and reaction vessels may contain appreciable amounts of sodium ions which will leach into the final product. Rinse the glassware carefully using nanopurewater for the last wash.
Identifying the molecular ion peaks also becomes difficult if the matrix solution is not fully saturated with the solid matrix. To ensure saturation, there should always be a small amount of the solid matrix that has not solubilized.
As a final note, please consider that some PPAs or PAs might not form any precipitate upon addition of ether. This was mainly observed in the more hydrophilic PPAs. In such events, we will first evaporate all ether, neutralize the excess TFA with NH4OH and add Water and Acetonitrile (with 0.1% TFA or NH4OH) to fully solubilize it and then proceed to purify as usual.
The protocol described here can be used to synthesize highly pure variants of self-assembling polyamine based peptide amphiphiles (PPAs) and also PAs. The orthogonal protection/deprotection steps can be used in other situations that require selective masking of primary and secondary amine groups.
The authors have nothing to disclose.
This project was funded by the University of Nebraska Medical Center (Start-up funds, MC-S); NIH-COBRE, 5P20GM103480 (T. Bronich) and the American Chemical Society, PRF# 57434-DNI7(MC-S).
2-Chlorotrityl chloride resin | AappTec | RTZ001 | |
SynthwareTM synthesis vessel | Aldrich | SYNP120050M | |
Dichloromethane | Acros | AC406920250 | Fisher Sci. Catalogue # |
Wrist Shaker | Boekel Scientific | 401000-2 | |
Kaiser test kit | Sigma-Aldrich | 60017 | |
2-[(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-amino]-ethanol | Sigma-Aldrich | CDS004772 | |
Anhydrous Methanol | Acros | AC610981000 | Fisher Sci. Catalogue # |
Chloranil test kit | TCI | TCC1771-KIT | VWR Catalogue # |
Di-tert butyl di-carbonate | Acros | AC194670250 | Fisher Sci. Catalogue # |
Dimethylformamide | Fisher Scientific | BP1160-4 | |
Hydrazine | Acros | AC296815000 | FIsher Sci. Catalogue # |
(2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) | p3biosystems | 31001 | |
4-methyl piperidine | Acros | AC127515000 | FIsher Sci. Catalogue # |
Trifluoroacetic Acid | AappTec | CXZ035 | |
Triisopropyl Silane | Sigma-Aldrich | 233781 | |
Ether | Fisher Scientific | E138-1 | |
α-Cyano-4-hydroxycinnamic acid | Sigma-Aldrich | C8982 | |
9-Aminoacridine | Sigma-Aldrich | 92817 | |
Fisherbrand Syringe Filters: PTFE Membrane | Fisher Scientific | 09-730-21 |